New MEDITECH Expanse Pathology Solution Streamlines Pathologist Workflows

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

The web-native design brings pathologists to the forefront of advancing care and connecting data throughout the EHR.


CANTON, Mass.–(BUSINESS WIRE)–MEDITECH announces the release of its redesigned Expanse Pathology solution — one of the company’s latest innovations in its Expanse EHR. As the pathology industry trends towards more specialized imaging and advanced integrated reporting with genetic results, Expanse Pathology provides the technology pathologists need to assist with the most complicated cases.

Expanse Pathology includes a new, streamlined workflow with an intuitive and personalizable space for pathologists aiming to reduce the cognitive burden of technically complicated tasks. Designed to support web-native navigation, Expanse Pathology positions laboratories to leverage the latest advancements in the pathology market today and in the future.

“As clinicians everywhere face burnout, the ability to leverage user-tailored worklists, capture findings efficiently using the latest technologies, and easily edit and sign out cases will save pathologists valuable time,” said MEDITECH Manager of Clinical Strategy Jennifer Ford.

“Plus, with the integration between Expanse Pathology and other groundbreaking MEDITECH solutions like Expanse Genomics and Expanse Oncology, we can drive better patient care and help pathologists connect the intricate dots of data throughout the Electronic Health Record, enabling true precision medicine.”

Expanse’s inherent integration brings the most important members of the care team into the loop when it matters. Pathologists can easily share important key findings with other clinicians and leverage Expanse Genomics to push key data to the forefront. In addition, synoptic reporting staging within Expanse Pathology flows directly to Expanse Oncology to assist oncologists and other clinicians while performing staging and making significant decisions about patient care.

“Pathologists are such an important part of a patient’s care team,” said Ford. “MEDITECH Expanse Pathology removes silos by providing pathologists with the tools necessary to increase efficiency and easily communicate information across the entire pathology department and beyond — from OB to Oncology — ensuring timely access to the most relevant information.”

Visit MEDITECH in booth #2580 at #HIMSS24 to learn more about Expanse Pathology.

About MEDITECH

MEDITECH empowers healthcare organizations around the globe to expand their vision of what’s possible with Expanse, the world’s most intelligent EHR platform. Expanse answers the demands of an overburdened workforce: personalized workflows, intuitive functionality, interoperable systems, and innovative AI applications, all working together to drive better outcomes. See why thousands of healthcare organizations in 27 countries and territories choose Expanse. Visit ehr.meditech.com and follow us on YouTube, LinkedIn, X/Twitter, Facebook, Instagram, and Threads.

Contacts

Robin Montville

Public and Media Relations Manager

MEDITECH

781-774-3370

rmontville@meditech.com

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

8 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

8 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

11 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

11 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

11 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

14 hours ago